Welcome to this UK AstraZeneca produced and funded website

This website is intended for UK Healthcare Professionals only.

 

The website contains both promotional and non-promotional content.

 

If you are a patient or a carer of a patient prescribed an AstraZeneca product, please visit myazmed.co.uk

 

For any other UK residents please visit astrazeneca.co.uk

I am not a Healthcare Professional
Prescribing Information FLUENZ® nasal spray suspension (influenza vaccine, live attenuated, nasal)
Adverse Event Reporting

This website is intended for UK Healthcare Professionals only. Other UK residents please visit astrazeneca.co.uk

AstraZeneca-logo
  • Our Medicines
    • Cardiovascular, Renal & Metabolism
      • ATTR Amyloidosis
        • WAINZUA®▼(eplontersen)
      • Chronic Kidney Disease (CKD)
        • FORXIGA® (dapagliflozin)
      • Heart Failure
        • FORXIGA® (dapagliflozin)
      • Hyperkalaemia
        • LOKELMA® (sodium zirconium cyclosilicate)
      • Type 2 Diabetes (T2D)
        • FORXIGA® (dapagliflozin)
    • Oncology
      • Breast Cancer
        • LYNPARZA® (olaparib)
        • TRUQAP®▼(capivasertib)
      • Bladder Cancer
        • IMFINZI® (durvalumab)
      • Endometrial Cancer
        • IMFINZI® (durvalumab)
        • LYNPARZA® (olaparib)
      • Gastrointestinal Cancer
        • IMFINZI® (durvalumab)
        • IMJUDO®▼(tremelimumab)
      • Lung Cancer
        • IMFINZI® (durvalumab)
        • TAGRISSO® (osimertinib)
      • Ovarian Cancer
        • LYNPARZA® (olaparib)
      • Prostate Cancer
        • LYNPARZA® (olaparib)
        • ZOLADEX® (goserelin)
    • Respiratory
      • Asthma
        • TEZSPIRE®▼ (tezepelumab)
        • SYMBICORT® (budesonide/formoterol)
      • Chronic Obstructive Pulmonary Disease(COPD)
        • TRIXEO AEROSPHERE® (formoterol fumarate dihydrate/glycopyrronium/budesonide)
        • BEVESPI® (glycopyrronium/formoterol fumarate dihydrate)
    • Vaccines
      • Flu
        • FLUENZ® nasal spray suspension (influenza vaccine, live attenuated, nasal)
  • Therapy Areas
    • Cardiovascular, Renal & Metabolism
      • ATTR Amyloidosis
      • Chronic Kidney Disease (CKD)
      • Heart Failure
      • Hyperkalaemia
      • Type 2 Diabetes (T2D)
    • Oncology
      • Breast Cancer
      • Bladder Cancer
      • Endometrial Cancer
      • Gastrointestinal Cancer
      • Lung Cancer
      • Ovarian Cancer
      • Prostate Cancer
    • Respiratory
      • Asthma
      • Chronic Obstructive Pulmonary Disease(COPD)
    • Vaccines
      • Flu
  • About us
    • AZ Commitment
  • Contact us
  • AstraZeneca UK
  • Welcome to Fluenz
  • Who is Eligible?
  • Welcome to Fluenz
  • About Fluenz
  • The Importance of Vaccination
  • Who is Eligible
  • FAQs and Training
  • Supportive Resources
Who is eligible this season?

 

Who is eligible this season?

Understand eligibility criteria for the childhood flu national immunisation programme this year.

Who can receive the childhood flu vaccine?

 

Each year, the UK government and the devolved nations determine what steps need to be taken with the flu vaccination programme to help support the NHS and social care over the winter period; part of this is to determine which cohorts are eligible for a free flu vaccination.1

Each year, they release a letter that sets this out for the coming season.

Fluenz is indicated for active immunisation for the prevention of influenza disease in children and adolescents from 2 years to less than 18 years of age. Fluenz should be used in accordance with official recommendations.2

Please consult the SmPC prior to use.

Who is eligible for a free nasal spray flu vaccine this season?

England Flag England Flag

England for 2025 - 20261

  • All children aged 2 or 3 years on 31 August
  • All primary school aged children (from Reception to Year 6)
  • Secondary school aged children (from Year 7 to Year 11)
Scotland flag Scotland flag

Scotland for 2025 - 20264

  • All children aged 2 to 5 years, not yet at school (children must be aged 2 years or above on 1 September)
  • All primary school children at school (P1 to P7)
  • All secondary school pupils at school (S1 up to and including S6)
Wales Flag Wales Flag

Wales for 2025 - 20263

  • All children aged 2 and 3 years on 31 August 
  • All school aged children from Reception to Year 11 (inclusive)
Northern Ireland flag Northern Ireland flag

Northern Ireland for 2025 - 20265

  • All preschool children aged 2 to 4 years on 1 September 
  • All primary and secondary school children (up to and including Year 12)

Since the very start of the childhood flu National Immunisation Programme in 2013, the nasal spray flu vaccine has been a part of the programme.6 If the nasal spray is not suitable, an alternative may be offered.

Sign up for more information

Stay up-to-date with the latest promotional and non-promotional service and product information.

Stay informed

Access supportive materials

Explore resources designed to support the teams administering the Fluenz nasal spray vaccine in schools and practices.

Discover resources

Get in touch

For additional administration support, request a call back

from the AZExchange team.

Contact us

  1. UK Health Security Agency, Department of Health & Social Care, and NHS England (2025) National flu immunisation programme 2025 to 2026 letter. Available at: https://www.gov.uk/government/publications/national-flu-immunisation-programme-plan-2025-to-2026/national-flu-immunisation-programme-2025-to-2026-letter (Accessed: June 2025).
  2. Fluenz nasal spray suspension influenza vaccine (live attenuated): Summary of Product Characteristics. Accessed March 2025. Available at: https://www.medicines.org.uk/emc/product/15790/smpc (Accessed: June 2025).
  3. Welsh Government (2025) Eligible groups in the 2025 to 2026 flu immunisation programme. Available at: https://www.gov.wales/eligible-groups-2025-2026-flu-immunisation-programme-html (Accessed: June 2025).
  4. Scottish Government, Chief Medical Officer Directorate (2025) Seasonal Influenza (Flu) Immunisation Programme 2025/26: Confirmation of adult and child cohorts, 14 April. Available at: https://www.publications.scot.nhs.uk/files/cmo-2025-06.pdf (Accessed: June 2025)
  5. NIDirect (2025) Flu vaccine: 2025 season eligibility. nidirect. Available at: https://www.nidirect.gov.uk/articles/flu-vaccine (Accessed: June 2025).
  6. Department of Health & Social Care (2024) JCVI statement on influenza vaccines for 2025 to 2026. GOV.UK. Available at: https://www.gov.uk/government/publications/flu-vaccines-2025-to-2026-jcvi-advice/jcvi-statement-on-influenza-vaccines-for-2025-to-2026 (Accessed: June 2025).

GB-68300 | DOP: July 2025

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com/ or by calling ‌‌‌0‌‌‌8‌‌‌‌‌0‌‌‌‌0‌‌‌ ‌‌7‌‌‌‌‌‌8‌‌‌3‌‌‌ ‌‌0‌‌‌‌‌0‌‌‌‌3‌‌‌‌3‌‌‌.

Connessiallasalute.it

This website was created for UK HCPs and has been designed to provide information to educate, empower and enable them in the great work they are doing for patients across a range of therapy areas. This website is intended for doctors, nurses, and pharmacists in the UK. Other UK residents please visit astrazeneca.co.uk.

Terms of use

Privacy Policy

Cookie Policy

Contact Us

LinkedIn

Twitter

©2024 AstraZeneca. GB-75991 | April 2026